Implementation and outcomes of a multidisciplinary high-risk breast cancer program: The William Beaumont Hospital experience

Clinical Breast Cancer

Volumn 12, Issue 3, 2012, Pages 215-218

  Shah, Chirag ^a   Berry, Sameer ^a   Dekhne, Nayana ^a   Lanni, Thomas ^a   Lowry, Heather ^a   Vicini, Frank ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Breast cancer; Gail model; High risk; Surveillance

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER SCREENING; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; LIFESPAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT REFERRAL; QUESTIONNAIRE; RELATIVE; REVIEW; RISK ASSESSMENT;

EID: 84861139724     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.03.002     Document Type: Article

References (17)

1. M.H. Gail, L.A. Brinton, D.P. Byar Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1989 1879 1886
2. B. Fisher, J.P. Costantino, D.L. Wickerham Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study J Natl Cancer Inst 97 2005 1652 1662
3. J. Cuzick, J. Forbes, R. Edwards First results from the international breast cancer intervention study (IBIS-I): a randomised prevention trial Lancet 360 2002 817 824
4. V.G. Vogel, J.P. Costantino, D.L. Wickerham Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial JAMA 295 2006 2727 2741
5. P.E. Goss, J.N. Ingle, J.E. Alés-Martínez Exemestane for breast-cancer prevention in postmenopausal women N Engl J Med 364 2011 2381 2391
6. L. Lostumbo, N.E. Carbine, J. Wallace Prophylactic mastectomy for the prevention of cancer Cochrane Database Syst Rev 10 2010 CD002748
7. B. Arver, K. Isaksson, H. Atterhem Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey Ann Surg 253 2011 1147 1154
8. M.L. Burness, O.L. Olopade Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy? J Clin Oncol 29 2011 1652 1654
9. C. Printz New data on BRCA mutations and prophylactic surgeries Cancer 117 2011 657
10. H.T. Le-Petross, M.K. Shetty Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients Semin Ultrasound CT MR 32 2011 266 272
11. E. Warner, K. Hill, P. Causer Prospective study of breast cancer incidence in women with BRCA1 or BRCA2 mutation under surveillance with wand without magnetic resonance imaging J Clin Oncol 29 2011 1664 1669
12. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-v.2.2011. National Comprehensive Cancer Network [Web site]. Breast cancer http://www.nccn.org/professionals/physician-gls/f-guidelines.asp Accessed: November 5, 2011
13. US Census Bureau Race, Hispanic or Latino, Age, and Housing Occupancy: 2010 Census Redistricting Data Summary File http://factfinder2.census.gov/faces/ nav/jsf/pages/index.xhtml Accessed: April 2, 2012
14. H.T. Le-Petross, G.J. Whitman, D.P. Atchley Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer Cancer 117 2011 3900 3907
15. W.L. Owens, T.J. Gallagher, M.J. Kincheloe Implementation in a large health system of a program to identify women at high risk high risk for breast cancer J Oncol Pract 7 2011 85 88
16. L.A. Snyder, D.B. Soballe, L.L. Lahl Development of the breast cancer education and risk assessment program Oncol Nurs Forum 30 2003 803 808
17. P.L. Chart, E. Franssen Management of women at increased risk for breast cancer: preliminary results from a new program CMAJ 157 1997 1235 1242